|
1
|
Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y,
Li P and Chang JY: Promising clinical outcome of stereotactic body
radiation therapy for patients with inoperable Stage I/II
non-small-cell lung cancer. Int J Radiat Oncol Biol Phys.
66:117–125. 2006. View Article : Google Scholar
|
|
2
|
Wu D, Zhu H, Tang H, Li C and Xu F:
Clinical analysis of stereotactic body radiation therapy using
extracranial γ knife for patients with mainly bulky inoperable
early stage non-small cell lung carcinoma. Radiat Oncol.
6:842011.
|
|
3
|
Haasbeek CJ, Senan S, Smit EF, Paul MA,
Slotman BJ and Lagerwaard FJ: Critical review of nonsurgical
treatment options for stage I non-small cell lung cancer.
Oncologist. 13:309–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chi A, Liao Z, Nguyen NP, Xu J, Stea B and
Komaki R: Systemic review of the patterns of failure following
stereotactic body radiation therapy in early-stage non-small-cell
lung cancer: clinical implications. Radiother Oncol. 94:1–11. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Palma D and Senan S: Stereotactic
radiation therapy: changing treatment paradigms for stage I
nonsmall cell lung cancer. Curr Opin Oncol. 23:133–139. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Palma D, Visser O, Lagerwaard FJ,
Belderbos J, Slotman BJ and Senan S: Impact of introducing
stereotactic lung radiotherapy for elderly patients with stage I
non-small-cell lung cancer: a population-based time-trend analysis.
J Clin Oncol. 28:5153–5159. 2010. View Article : Google Scholar
|
|
7
|
Timmerman R, McGarry R, Yiannoutsos C,
Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C,
Williams M and Fletcher J: Excessive toxicity when treating central
tumors in a phase II study of stereotactic body radiation therapy
for medically inoperable early-stage lung cancer. J Clin Oncol.
24:4833–4839. 2006. View Article : Google Scholar
|
|
8
|
Chang JY, Balter PA, Dong L, Yang Q, Liao
Z, Jeter M, Bucci MK, McAleer MF, Mehran RJ, Roth JA and Komaki R:
Stereotactic body radiation therapy in centrally and superiorly
located stage I or isolated recurrent non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 72:967–971. 2008. View Article : Google Scholar
|
|
9
|
Lagerwaard FJ, Haasbeek CJ, Smit EF,
Slotman BJ and Senan S: Outcomes of risk-adapted fractionated
stereotactic radiotherapy for stage I non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 70:685–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haasbeek CJ, Lagerwaard FJ, Slotman BJ and
Senan S: Outcomes of stereotactic ablative radiotherapy for
centrally-located early-stage lung cancer. J Thorac Oncol.
6:2036–2043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oshiro Y, Aruga T, Tsuboi K, Marino K,
Hara R, Sanayama Y and Itami J: Stereotactic body radiotherapy for
lung tumors at the pulmonary hilum. Strahlenther Onkol.
186:274–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Unger K, Ju A, Oermann E, Suy S, Yu X,
Vahdat S, Subramaniam D, Harter KW, Collins SP, Dritschilo A,
Anderson E and Collins BT: CyberKnife for hilar lung tumors: report
of clinical response and toxicity. J Hematol Oncol. 3:392010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nuyttens JJ, van der Voort van Zyp NC,
Praag J, Aluwini S, van Klaveren RJ, Verhoef C, Pattynama PM and
Hoogeman MS: Outcome of four-dimensional stereotactic radiotherapy
for centrally-located lung tumors. Radiother Oncol. 102:383–387.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Joyner M, Salter BJ, Papanikolaou N and
Fuss M: Stereotactic body radiation therapy for centrally-located
lung lesions. Acta Oncol. 45:802–807. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen G, Wang YJ, Sheng HG, Duan XP, Wang
JL, Zhang WJ, Zhou ZS, Zhu GY and Xia TY: Double CT imaging can
measure the respiratory movement of small pulmonary tumors during
stereotactic ablative radiotherapy. J Thorac Dis. 4:131–140.
2012.PubMed/NCBI
|
|
16
|
Zhang LP, Nie Q, Kang JB, Wang B, Cai CL,
Li JG and Qi WJ: Efficacy of whole body γ-knife radiotherapy
combined with thermochemotherapy on locally advanced pancreatic
cancer. Ai Zheng. 27:1204–1207. 2008.(In Chinese).
|
|
17
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, et al: New guidelines to
evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer
Institute of the United States, National Cancer Institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colevas AD and Setser A: The NCI Common
Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new
standard for oncology clinical trials. J Clin Oncol. 22(July 15
Suppl): 60982004.
|
|
19
|
Miller KL, Shafman TD, Anscher MS, Zhou
SM, Clough RW, Garst JL, Crawford J, Rosenman J, Socinski MA,
Blackstock W, Sibley GS and Marks LB: Bronchial stenosis: an
underreported complication of high-dose external beam radiotherapy
for lung cancer? Int J Radiat Oncol Biol Phys. 61:64–69. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bral S, Gevaert T, Linthout N, Versmessen
H, Collen C, Engels B, Verdries D, Everaert H, Christian N, De
Ridder M and Storme G: Prospective, risk-adapted strategy of
stereotactic body radiotherapy for early-stage non-small-cell lung
cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys.
80:1343–1349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wulf J, Hädinger U, Oppitz U, Thiele W,
Ness-Dourdoumas R and Flentje M: Stereotactic radiotherapy of
targets in the lung and liver. Strahlenther Onkol. 177:645–655.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheruvu P, Metcalfe SK, Metcalfe J, Chen
Y, Okunieff P and Milano MT: Comparison of outcomes in patients
with stage III versus limited stage IV non-small cell lung cancer.
Radiat Oncol. 6:802011. View Article : Google Scholar : PubMed/NCBI
|
